A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial

INTRODUCTION: Critically ill patients are predisposed to venous thromboembolism. We hypothesized that higher doses of enoxaparin would improve thromboprophylaxis without increasing the risk of bleeding. Peak anti-factor Xa (anti-Xa) levels of 0.1 to 0.4 IU/ml reflect adequate thromboprophylaxis for...

Full description

Saved in:
Bibliographic Details
Main Authors: Robinson, Sian, Zincuk, Aleksander, Larsen, Ulla Lei, Ekstrøm, Claus, Nybo, Mads, Rasmussen, Bjarne, Toft, Palle
Format: Artigo
Language:Inglês
Published: BioMed Central 2013
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4057520/
https://ncbi.nlm.nih.gov/pubmed/23601744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc12684
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items